Alterations of the kynurenine pathway in patients with type 1 diabetes are associated with metabolic control of diabetes
Pol Arch Intern Med
.
2023 Nov 29;133(11):16581.
doi: 10.20452/pamw.16581.
Epub 2023 Oct 5.
Authors
Małgorzata Kiluk
1
,
Janina Lewkowicz
2
,
Irina Kowalska
2
,
Dariusz Pawlak
3
,
Katarzyna Łagoda
2
4
,
Anna Tankiewicz-Kwedlo
5
Affiliations
1
Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Białystok, Poland. malgorzatakiluk@gmail.com
2
Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Białystok, Poland
3
Department of Pharmacodynamics, Medical University of Bialystok, Białystok, Poland
4
Department of Clinical Medicine, Medical University of Bialystok, Białystok, Poland
5
Department of Monitored Pharmacotherapy, Medical University of Bialystok, Białystok, Poland
PMID:
37795878
DOI:
10.20452/pamw.16581
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Diabetes Mellitus, Type 1* / complications
Humans
Kynurenine* / metabolism
Substances
Kynurenine